REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07365839 updates: 1. start date: 2026-07-01 → 2026-10-01 2. completion date: 2035-02-28 → 2035-05-28 3. primary completion date: 2035-02-28 → 2035-05-28
Clinical trial NCT07365839 updates: 1. start date: 2026-07-01 → 2026-10-01 2. completion date: 2035-02-28 → 2035-05-28 3. primary completion date: 2035-02-28 → 2035-05-28
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical